Hemocellular Therapeutics

Hemocellular Therapeutics is a Vancouver-based biotechnology company focused on developing next-generation blood-based therapies through advanced cell surface engineering. The company's proprietary platform utilizes biocompatible polymers to modify the surface of red blood cells and platelets, enabling the masking of antigens and the attachment of therapeutic agents. This approach allows for the creation of universal donor blood products and the development of targeted delivery systems for immune-modulating drugs. Hemocellular's primary therapeutic focus includes autoimmune diseases, transplant rejection, and hematological disorders. By transforming blood cells into sophisticated drug delivery vehicles, the company aims to enhance the precision and safety of systemic treatments.